The Treatment Gap

Kale, Rajendra

doi:10.1046/j.1528-1157.43.s.6.13.x

Cited by 121 publications

(60 citation statements)

References 16 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of the more than 40 million individuals with epilepsy 80% live in developing countries where the vast majority does not receive appropriate treatment The reported size of the epilepsy TG in subSaharan Africa varies widely, ranging from 23% in Senegal to 100% in Uganda, Tanzania, Gambia, and Togo 15,16,17 . A 2003 study estimated a TG of 70.3% in the rural Kilifi district of Kenya based on undetectable amounts of anti-epileptic drugs in blood samples of people with active convulsive epilepsy 11 .…”

Section: Assessing the Treatment Gapmentioning

confidence: 99%

Epilepsy treatment in sub-Saharan Africa: closing the gap

Chin¹

2012

Af Hlth Sci

View full text Add to dashboard Cite

SummaryAccording to World Health Organization (WHO), the prevalence of epilepsy is highest in low-and lower middle-income countries, which include over eighty percent of the countries of sub-Saharan Africa, where the majority of people with epilepsy are not receiving appropriate care. In sub-Saharan Africa, shortages of trained health workers, limited diagnostic equipment, inadequate anti-epileptic drug supplies, cultural beliefs, and social stigma contribute to the large treatment gap for epilepsy. The number of people with epilepsy, particularly children, will continue to rise as a result of projected epidemiologic and demographic changes. This paper examines the state of epilepsy care and treatment in sub-Saharan Africa and discusses priorities and approaches to scale up access to medications and services for people with epilepsy.

show abstract

Section: Assessing the Treatment Gapmentioning

confidence: 99%

Epilepsy treatment in sub-Saharan Africa: closing the gap

Chin¹

2012

Af Hlth Sci

View full text Add to dashboard Cite

show abstract

“…More than 500 million people are indirectly affected by epilepsy as parents, relatives and friends [2]. The World Bank has prioritized epilepsy as a highly cost-effective condition to treat [3] since relatively inexpensive antiepileptic drugs (AEDs) are very effective in controlling seizures: with up to 75% of those treated will become seizure free [4].…”

Section: Introductionmentioning

confidence: 99%

The reasons for the epilepsy treatment gap in Kilifi, Kenya: Using formative research to identify interventions to improve adherence to antiepileptic drugs

Carter

Molyneux

Mbuba

et al. 2012

Epilepsy & Behavior

View full text Add to dashboard Cite

Many people with epilepsy (PWE) in resource‐poor countries do not receive appropriate treatment, a phenomenon referred to as the epilepsy treatment gap (ETG). We conducted a qualitative study to explore the reasons for this gap and to identify possible interventions in Kilifi, Kenya. Focus group discussions (FGDs) were carried out of PWE and their caregivers. Individual interviews were conducted of PWE, their caregivers, traditional healers, community health workers and leaders, nurses and doctors. In addition, a series of workshops was conducted, and four factors contributing to the ETG were identified: 1) lack of knowledge about the causes, treatment and prognosis of epilepsy; 2) inaccessibility to antiepileptic drugs; 3) misconceptions about epilepsy derived from superstitions about its origin; 4) and dissatisfaction with the communication skills of health providers. These data indicated possible interventions: 1) education and support for PWE and their caregivers; 2) communication skills training for health providers; 3) and improved drug provision.

show abstract

“…Около 500 млн родственни ков и коллег тем или иным образом участвуют в решении проблем больных эпилепсией [12]. В раз витых странах ее распространенность колеблется от 1,5 до 18 человек на 1000 населения, а в неко торых развивающихся странах превышает 30 на 1000 населения.…”

Section: Introductionunclassified